Share

June 2013; 3 (3) Eye on Practice

Practice and payment trends in neurology in 2012

Karolina Craft, Peter Donofrio, Katie M. Shepard, Mary Coleman, Gregory J. Esper
First published June 10, 2013, DOI: https://doi.org/10.1212/CPJ.0b013e318296f2ef
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
160

Share

Article Information

vol. 3 no. 3 233-239
DOI: 
https://doi.org/10.1212/CPJ.0b013e318296f2ef
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published June 10, 2013.
Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Karolina Craft, MA,
    2. Peter Donofrio, MD,
    3. Katie M. Shepard,
    4. Mary Coleman and
    5. Gregory J. Esper, MD, MBA
  1. Karolina Craft, MA,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. American Academy of Neurology, Manager, Policy Analysis

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Peter Donofrio, MD,
    3. Scientific Advisory Boards:

    1. CSL Behring Baxter

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Talecris Pharmceuticals

    Editorial Boards:

    1. Muscle & Nerve, editorial board, 20008-2013

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Knopp Pharmaceuticals

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Expert witness for defendent-Pfizer

  3. Katie M. Shepard,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. American Academy of Neurology, Associate Director Medical Economics

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Mary Coleman and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. American Academy of Neurology, received salary as an employee of the AAN, 2006-2013

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Gregory J. Esper, MD, MBA
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Maglio, Christopher and Toale Law firm, expert witness, vaccine induced neurological diseases, 2010-2012

  1. American Academy of Neurology, Minneapolis, MN.
  1. Correspondence to:
    kcraft{at}aan.com
View Full Text

Article usage

Article usage: May 2013 to December 2021

AbstractFullPdfSource
May 2013011Highwire
Jun 20133572331Highwire
Jul 201318994Highwire
Aug 201323811160Highwire
Sep 20139162Highwire
Oct 20137322Highwire
Nov 20137110Highwire
Dec 20135924Highwire
Jan 20147211Highwire
Feb 20144700Highwire
Mar 20143202Highwire
Apr 20143201Highwire
May 20142701Highwire
Jun 20144001Highwire
Jul 20141600Highwire
Aug 20141911Highwire
Sep 20141100Highwire
Oct 20141300Highwire
Nov 20142712Highwire
Dec 2014900Highwire
Jan 20151801Highwire
Feb 2015910Highwire
Mar 20155601Highwire
Apr 20151800Highwire
May 20151702Highwire
Jun 20151701Highwire
Jul 20151601Highwire
Aug 20151001Highwire
Sep 20151410Highwire
Oct 20151600Highwire
Nov 20152801Highwire
Dec 20151300Highwire
Jan 2016700Highwire
Feb 20162611Highwire
Mar 20161311Highwire
Apr 2016901Highwire
May 20161700Highwire
Jun 20161912Highwire
Jul 20162101Highwire
Aug 20161300Highwire
Sep 20162801Highwire
Oct 20161700Highwire
Nov 20162500Highwire
Dec 20164302Highwire
Jan 20172600Highwire
Feb 20171500Highwire
Mar 20172100Highwire
Apr 20172401Highwire
May 20171200Highwire
Jun 20171100Highwire
Jul 2017800Highwire
Aug 20171200Highwire
Sep 2017900Highwire
Oct 20172311Highwire
Nov 20172301Highwire
Dec 20171300Highwire
Jan 2018900Highwire
Feb 20181911Highwire
Mar 20184520Highwire
Apr 20181410Highwire
Apr 2018133pmc
May 20183102Highwire
Jun 20182300Highwire
Jun 2018066pmc
Jul 20181300Highwire
Aug 20181610Highwire
Aug 2018099pmc
Sep 20181100Highwire
Oct 20181300Highwire
Nov 20181300Highwire
Dec 20185000Highwire
Jan 20193710Highwire
Feb 20192810Highwire
Mar 20192511Highwire
Apr 20191210Highwire
May 20191912Highwire
Jun 2019931Highwire
Jul 2019700Highwire
Aug 2019200Highwire
Sep 2019910Highwire
Oct 2019510Highwire
Nov 20191610Highwire
Dec 20191610Highwire
Jan 2020510Highwire
Feb 2020710Highwire
Mar 2020510Highwire
Apr 2020300Highwire
May 2020600Highwire
Jun 2020400Highwire
Jul 2020400Highwire
Aug 20203100Highwire
Sep 2020900Highwire
Oct 20201100Highwire
Nov 2020510Highwire
Dec 2020610Highwire
Jan 2021720Highwire
Feb 2021500Highwire
Mar 20211010Highwire
Apr 2021911Highwire
May 2021620Highwire
Jun 2021210Highwire
Jul 2021820Highwire
Aug 20211520Highwire
Sep 2021900Highwire
Oct 20211710Highwire
Nov 20211201Highwire
Dec 2021800Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me